MAYPHARM introduces HYALMASS AQUATOX, their innovative new skincare formula combining five powerful ingredients for global aesthetic needs.

MAYPHARM has announced the upcoming launch of HYALMASS AQUATOX, a cutting-edge multi-active skin solution combining five potent ingredients for the global aesthetic market.

Discover MAYPHARM's innovative skincare solution, HYALMASS AQUATOX, a multi-active formulation designed for the evolving needs of aesthetic medicine worldwide.

MAYPHARM's HYALMASS AQUATOX is a groundbreaking skin solution featuring five potent actives aimed at meeting demands in the aesthetic market.

سيول، كوريا الجنوبية، 26 سبتمبر، 2026/PRNewswire/ — أعلنت شركة “ماي فارم” (MAYPHARM)، وهي شركة عالمية لمنتجات الطب التجميلي ومستحضرات التجميل، عن الإطلاق القادم لمنتج HYALMASS AQUATOX ، حيث أطلقت تركيبة جديدة متعددة المكونات النشطة مصممة للاستجابة للطلبات سريعة التطور في سوق الطب التجميلي العالمي. بدلاً من الاعتماد على مكون واحد رائج، يجمع HYALMASS AQUATOX خمسة [...] The post MAYPHARM تكشف عن HYALMASS AQUATOX ، حل للبشرة متعدد المكونات النشطة من الجيل التالي لسوق الطب التجميلي العالمي appeared first on اليوم السابع - Alyoum Alsabea.

Die Hautpflegeformel kombiniert fünf Komponenten für den internationalen Ästhetikmarkt; ein Termin für den weltweiten Verkauf steht noch aus.

SEOUL, South Korea, Sept. 26, 2026 /PRNewswire/ — MAYPHARM, a global aesthetic and cosmeceutical company, has announced the upcoming launch of HYALMASS AQUATOX, introducing a new multi-active formulation designed to respond to the rapidly evolving demands of the global aesthetic market. Rather than relying on a single trending ingredient, HYALMASS AQUATOX brings together five high-interest […]

MAYPHARM's SKINCOLLA is a groundbreaking recombinant human collagen filler designed for superior skin rejuvenation and enhancement, offering natural-looking results.

MAYPHARM CO., LTD. unveils SKINCOLLA, the first recombinant human collagen filler that promises superior skin rejuvenation, enhancing texture, elasticity, and hydration.

MAYPHARM has launched SKINCOLLA, the world's first recombinant human collagen filler, offering a significant advancement in skin rejuvenation technology and results.

MAYPHARM CO., LTD. has unveiled SKINCOLLA, the world's first recombinant human collagen filler, designed for effective skin rejuvenation and hydration.

The new Hyalmass Aqua-Exosome by Maypharm combines hyaluronic acid, exosomes, and PDRN to enhance skin hydration, elasticity, and regeneration.

Maypharm unveils Hyalmass Aqua-Exosome, an innovative hybrid filler that redefines skin hydration and restoration using exosomes and PDRN.

Maypharm Co, Ltd introduces Hyalmass Aqua-Exosome, a revolutionary hybrid filler that promises enhanced skin hydration and regeneration through innovative technology.

Discover Maypharm's innovative Hyalmass Aqua-Exosome, a game-changing hybrid filler that enhances skin hydration, elasticity, and regeneration.

Maypharm introduces Hyalmass Aqua-Exosome, a groundbreaking hybrid filler that enhances skin hydration and rejuvenation with advanced technology.

Unapproved New Drugs/Misbranded Botox

Bahnbrechende Technologie kombiniert rekombinantes menschliches Kollagen und Hyaluronsäure für sofortige, lang anhaltende Ergebnisse SEOUL, Südkorea, 16. Februar 2025 /PRNewswire/ -- MAYPHARM CO., LTD. stellt mit Stolz SKINCOLLA vor, den weltweit ersten…

Cette technologie révolutionnaire associe le collagène humain recombinant et l'acide hyaluronique pour des résultats immédiats et durables SÉOUL, Corée du Sud, 14 février 2025 /PRNewswire/ -- MAYPHARM CO. LTD. est fier de présenter SKINCOLLA, le premier…

-MAYPHARM CO., LTD. lanza SKINCOLLA: El primer relleno de colágeno humano recombinante del mundo para un rejuvenecimiento superior de la piel Una tecnología innovadora que combina colágeno humano recombinante y ácido hialurónico para obtener resultados…

Groundbreaking Technology Combines Recombinant Human Collagen and Hyaluronic Acid for Immediate, Long-Lasting Results SEOUL, South Korea, Feb. 14, 2025 /PRNewswire/ -- MAYPHARM CO., LTD. proudly introduces SKINCOLLA, the world's first recombinant human…

Présentation de l'acide hyaluronique, des exosomes et du PDRN SÉOUL, Corée du Sud, 30 décembre 2024 /PRNewswire/ -- Maypharm Co, Ltd, l'un des principaux innovateurs en matière de produits médicaux et dermo-cosmétiques, introduit avec fierté Hyalmass…

- Maypharm presenta Hyalmass Aqua-Exosome, un revolucionario relleno híbrido: el futuro de la hidratación y regeneración de la piel Introducción al ácido hialurónico, los exosomas y el PDRN SEÚL, Corea del Sur, 30 de diciembre de 2024 /PRNewswire/ --…